Korea's KTB-KORUS Fund backs $20m round in biotech firm ORIG3N

Korea's KTB-KORUS Fund backs $20m round in biotech firm ORIG3N

Shiwen Yap

30 June, 2017

180 Degree CapitalDEFTA PartnersHatteras Venture PartnersIncKTB VenturesKTB-KORUS FundLabCorpMGC Venture PartnersMountain Group PartnersORIG3NSpectrum Health Ventures (SHV)Syno Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.